Analogously, PTC596 has been demonstrated to counteract EMT, in agreement with the literature reporting that BMI-1, the target of PTC596, promotes cancer migration and invasion by modulating the expression of EMT-related proteins [30]. The gene discussed is BMI1; the disease is cancer.